The Revised International Staging System Compared to the Classical International Staging System Better Discriminates Risk Groups among Transplant-Ineligible Multiple Myeloma Patients.

Oncol Res Treat 2017 19;40(10):616-620. Epub 2017 Sep 19.

Clinic of Hematology, ClinicalCenter Serbia, Belgrade, Serbia.

Background: The Revised International Staging System (R-ISS) has recently been introduced as a comprehensive prognostic score for multiple myeloma (MM). Validation of the R-ISS in patients treated outside of clinical trials is the focus of current investigations. The aim of this study was to test the prognostic role of the R-ISS in MM patients ineligible for autologous stem cell transplantation.

Patients And Methods: A total of 102 newly diagnosed MM patients were analyzed. All patients were initially treated with thalidomide-based combinations.

Results: An overall response rate was achieved in 77.4% patients. Both the International Staging System (ISS) and the R-ISS influenced the event-free survival and the overall survival (OS). However, the ISS was unable to discriminate patients in stages ISS1 and ISS2 regarding OS. On the contrary, the R-ISS clearly differentiated risk categories regarding OS and provided an improved discriminative power of 6.3% compared to the ISS. Furthermore, among the parameters that were significant in univariate analysis (presence of renal impairment, anemia, platelet count < 130 × 109/l, and R-ISS), the multivariate model pointed to the R-ISS (p = 0.001) as the most important parameter influencing OS.

Conclusion: The R-ISS represents a useful tool for risk stratification of transplant-ineligible MM patients and should be considered as a prognostic index in daily clinical practice.

Download full-text PDF

Source
http://dx.doi.org/10.1159/000478935DOI Listing
October 2018
49 Reads

Publication Analysis

Top Keywords

staging system
16
international staging
16
r-iss
8
patients
8
multiple myeloma
8
r-iss patients
8
revised international
8
discriminate patients
4
unable discriminate
4
survival iss
4
patients stages
4
survival survival
4
iss unable
4
iss2 contrary
4
differentiated risk
4
risk categories
4
categories provided
4
clearly differentiated
4
r-iss clearly
4
iss1 iss2
4

Similar Publications